Impel NeuroPharma Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Impel NeuroPharma Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10415
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Impel NeuroPharma Inc (Impel) is a clinical-stage biotechnology company that which develops intranasal drug treatments for central nervous system disorders. The company’s product pipeline includes INP104, INP103, INP102, INP101, INP105, and INP106. It also develops Precision Olfactory Delivery technology, a nasal drug delivery platform that delivers drugs for improved biodistribution. Impel’s products are used for the treatment of pain, depression, bipolar disorder, Alzheimer’s disease, migraine and Parkinson’s disease, among others. The company serves pharmaceutical and biotechnology companies, and premier academic research institutions. Impel is headquartered in Seattle, Washington, the US.

Impel NeuroPharma Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Impel NeuroPharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Impel NeuroPharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Impel NeuroPharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Impel NeuroPharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Impel NeuroPharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Impel NeuroPharma Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Impel NeuroPharma Raises USD21 Million in First Tranche of Series C Financing 10
Impel NeuroPharma Raises USD22.3 Million in Venture Financing 11
Impel NeuroPharma Raises USD0.08 Million in Venture Financing 12
Impel NeuroPharma Raises USD1.1 Million Financing 13
Impel NeuroPharma Raises USD4 Million in First Tranche of Series B Financing 14
Impel Neuropharma Raises US$2.6 Million In Venture Financing 15
Impel Neuropharma Raises US$0.03 Million In Venture Financing 16
Partnerships 17
Impel NeuroPharma and Camargo Pharma Enter into Agreement 17
Impel NeuroPharma Inc – Key Competitors 18
Impel NeuroPharma Inc – Key Employees 19
Impel NeuroPharma Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Strategy And Business Planning 21
Sep 13, 2017: Impel Neuropharma: New Headquarters at 201 Elliott 21
Corporate Communications 22
Nov 07, 2018: Impel NeuroPharma names Ellen A. Lubman as chief business officer 22
Oct 03, 2017: Impel NeuroPharma Board Announces Appointment of Jon Congleton as CEO 23
Mar 03, 2017: Veteran Biotech Executive Timothy S. Nelson Joins Impel’s Board of Directors 24
Other Significant Developments 25
Feb 07, 2017: Impel NeuroPharma Partners with Camargo Pharmaceutical Services for Development Programs 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Impel NeuroPharma Inc, Medical Equipment, Key Facts 2
Impel NeuroPharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Impel NeuroPharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Impel NeuroPharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Impel NeuroPharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Impel NeuroPharma Inc, Deals By Market, 2012 to YTD 2018 8
Impel NeuroPharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Impel NeuroPharma Raises USD21 Million in First Tranche of Series C Financing 10
Impel NeuroPharma Raises USD22.3 Million in Venture Financing 11
Impel NeuroPharma Raises USD0.08 Million in Venture Financing 12
Impel NeuroPharma Raises USD1.1 Million Financing 13
Impel NeuroPharma Raises USD4 Million in First Tranche of Series B Financing 14
Impel Neuropharma Raises US$2.6 Million In Venture Financing 15
Impel Neuropharma Raises US$0.03 Million In Venture Financing 16
Impel NeuroPharma and Camargo Pharma Enter into Agreement 17
Impel NeuroPharma Inc, Key Competitors 18
Impel NeuroPharma Inc, Key Employees 19

List of Figures
Impel NeuroPharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Impel NeuroPharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Impel NeuroPharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Impel NeuroPharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Impel NeuroPharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Impel NeuroPharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Impel NeuroPharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Impel NeuroPharma Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Impel NeuroPharma Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Empire Energy Group Ltd (EEG):企業の財務・戦略的SWOT分析
    Summary Empire Energy Group Ltd (EEGL), formerly Imperial Corp Ltd is an oil and gas company that offers exploration and production programs. The company produces and develops oil and gas assets; and has interest in onshore oil and gas fields in Mid Con property and Appalachia property. It has onsho …
  • Highmark Inc-製薬・医療分野:企業M&A・提携分析
    Summary Highmark Inc (Highmark), a subsidiary of Highmark Health, is a provider of healthcare insurance solutions. The company underwrites various indemnities and offers healthcare insurance products to individuals, families, groups, companies and federal employees. In addition, the company provides …
  • F-star Biotechnology Ltd-製薬・医療分野:企業M&A・提携分析
    Summary F-star Biotechnology Ltd (F-star) is a drug development company that offers novel bispecific antibodies. The company develops immuno-oncology bispecific antibody therapeutics. Its technologies comprise modular antibody technology, a proprietary engine that generates bispecific antibodies; mA …
  • China Life Insurance (Overseas) Company Limited:企業の戦略・SWOT・財務情報
    China Life Insurance (Overseas) Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Life Insurance (Overseas) Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Icelandair Group:企業の戦略・SWOT・財務情報
    Icelandair Group - Strategy, SWOT and Corporate Finance Report Summary Icelandair Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Galp Energia SGPS SA (GALP):石油・ガス:M&Aディール及び事業提携情報
    Summary Galp Energia SGPS SA (Galp) is an integrated energy company. It explores for, develops and produces crude oil and natural gas, refines crude oil, and markets refined petroleum products. The company also conducts power generation, produces biodiesel and trades gas. It imports, transports and …
  • Konica Minolta Inc (4902):医療機器:M&Aディール及び事業提携情報
    Summary Konica Minolta, Inc. (Konica Minolta) develops, manufactures and sells printing systems and solutions for production print professionals. The company’s product portfolio includes multi-functional peripherals (MFPs), printers, equipment for production print systems and graphic arts, equipment …
  • Accelerate Resources Ltd (AX8):企業の財務・戦略的SWOT分析
    Accelerate Resources Ltd (AX8) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • SM Energy Co (SM):石油・ガス:M&Aディール及び事業提携情報
    Summary SM Energy Co (SM Energy) is an independent upstream oil and gas company. It carries out the acquisition, exploration, development, and production of crude oil, natural gas and natural gas liquids (NGLs) in onshore North America. The company’s operations are concentrated in three onshore oper …
  • Acobiom:企業の製品パイプライン分析2018
    Summary Acobiom is a biotechnology company that specializes in biomarker discovery and development of innovative diagnostics. The company undertakes the discovery of RNA and DNA biomarkers, which finds application in the areas of disease detection and classification, patient stratification, companio …
  • Edison SpA (EDNR):企業の財務・戦略的SWOT分析
    Edison SpA (EDNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • EnBW Energie Baden-Wurttemberg AG (EBK):企業の財務・戦略的SWOT分析
    EnBW Energie Baden-Wurttemberg AG (EBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Feldan Bio Inc-製薬・医療分野:企業M&A・提携分析
    Summary Feldan Bio Inc (Feldan) is a biotechnology company. It discovers, develops, manufactures and markets research therapeutic and industrial protein products. The company offers cell therapy products, genome editing products and research products. Its genome editing product includes recombinant …
  • Claris Lifesciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Claris Lifesciences Ltd (Claris) is a manufacturer of generic drugs and pharmaceutical products. The company provides generic drugs that are directly injected into the human body, which is mainly used in the treatment of critical illnesses. It provides products are offered through various de …
  • Repower AG:電力:M&Aディール及び事業提携情報
    Summary Repower AG (Repower), formerly Ratia Energie AG is an energy company that produces, transmits and distributes electricity. The company's services include trading, market access, and sales support services. It generates electric energy from hydropower, wind power plants, and combined-cycle ga …
  • Sunrun Inc (RUN):企業の財務・戦略的SWOT分析
    Sunrun Inc (RUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • NeuroMetrix Inc (NURO):企業の財務・戦略的SWOT分析
    Summary NeuroMetrix Inc (NeuroMetrix) is a healthcare company company that develops wearable medical technology and point of care test to manage chronic pain, nerve diseases, and sleep disorders. The company’s products include quell wearable pain relief device, quell health cloud, DPNCheck point-of- …
  • Bank Dhofar SAOG:企業の戦略・SWOT・財務分析
    Bank Dhofar SAOG - Strategy, SWOT and Corporate Finance Report Summary Bank Dhofar SAOG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Marston’s PLC:企業の戦略・SWOT・財務情報
    Marston's PLC - Strategy, SWOT and Corporate Finance Report Summary Marston's PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Wesfarmers Limited:企業の戦略・SWOT・財務情報
    Wesfarmers Limited - Strategy, SWOT and Corporate Finance Report Summary Wesfarmers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆